Dergiler / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 2

Bismuth intoxication resulting in acute kidney injury in a pregnant adolescent girl

Sayfa
292–296
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In casesof AKI due to an overdose of CBS, treatment with dimercaprol combinedwith high flux hemodiafiltration and subsequently hemodialysis appears tobe both useful and safe for bismuth elimination.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Bismuth intoxication is a rare cause of acute kidney injury (AKI) and isusually reversible by appropriate therapeutic measures.
📊
Temel Bulgular & Veri:We present here acase of an adolescent pregnant girl who developed AKI due to an overdoseof colloidal bismuth subcitrate (CBS, total amount of 6 g).
💡
Sonuç & Katkı:In casesof AKI due to an overdose of CBS, treatment with dimercaprol combinedwith high flux hemodiafiltration and subsequently hemodialysis appears tobe both useful and safe for bismuth elimination.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Bismuth intoxication is a rare cause of acute kidney injury (AKI) and isusually reversible by appropriate therapeutic measures. We present here acase of an adolescent pregnant girl who developed AKI due to an overdoseof colloidal bismuth subcitrate (CBS, total amount of 6 g). She receivedparenteral chelating agent dimercaprol for 14 days. Continuous venovenoushemodiafiltration (CVVHD) with high-flux membrane was carried out in thefirst 3 days of chelating therapy and intermittent hemodialysis for 11 days,thereafter. The patient recovered clinically and was discharged after 21 days.She gave birth to a healthy term boy. At the last visit, the baby was 6 monthsold with normal growth and development as well as normal kidney functions.Neither deterioration in renal functions nor emergence of proteinuria wasrecorded in the patient during follow-up care after hospital discharge. In casesof AKI due to an overdose of CBS, treatment with dimercaprol combinedwith high flux hemodiafiltration and subsequently hemodialysis appears tobe both useful and safe for bismuth elimination.

🔖

Bu Makaleye Atıf Yap

TAYFUR, A. Ç., YARADILMIŞ, R. M., ULUS, F., YILMAZ, A. Ç., ÖZAYAR, E., KOŞAR, B., BÜYÜKKARAGÖZ, B., HORASANLI, E. (2019). Bismuth intoxication resulting in acute kidney injury in a pregnant adolescent girl. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 2, 292–296. https://ajindex.com/articles/412050

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Keogan DM, Griffith DM. Current and potential applications of bismuth-based drugs. Molecules 2014; 19: 15258-15297
  2. Lambert JR, Midolo P. The actions of bismuth in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11 (Suppl 1): 27-33
  3. Wagstaff AJ, Benfield P, Monk JP. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs 1988; 36: 132-157
  4. Bradley B, Singleton M, Li Wan Po A. Bismuth toxicity-a reassesment. J Clin Pharm Therapeut 1989; 14: 423-441
  5. Sun H, Li H, Mason AB, Woodworth RC, Sadler PJ. Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma. J Biol Chem 2001; 276: 8829-8835
  6. Sun H, Szeto KY. Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma. J Inorg Biochem 2003; 94: 114-120
  7. Erden A, Karahan S, Bulut K, et al. A case of bismuth intoxication with irreversible renal damage. Int J Nephrol Renovasc Dis 2013; 6: 241-243
  8. Cengiz N, Uslu Y, Gök F, Anarat A. Acute renal failure after overdose of colloidal bismuth subcitrate. Pediatr Nephrol 2005; 20: 1355-1358
  9. Serfontein WJ, Mekel R. Bismuth toxicity in man II. Review of bismuth blood and urine levels in patients after administration of therapeutic bismuth formulations in relation to the problem of bismuth toxicity in man. Res Commun Chem Pathol Pharmacol 1979; 26: 391-411
  10. Leussink BT, Slikkerveer A, Krauwinkel WJ, et al. Bismuth biokinetics and kidney histopathology after bismuth overdose in rats. Arch Toxicol 2000; 74: 349-355
  11. Hruz P, Mayr M, Low R, Drewe J, Huber G. Fanconi’s syndrome, acute renal failure, and tonsil ulcerations after colloidal bismuth subcitrate intoxication. Am J Kidney Dis 2002; 39: E18
  12. Boertz J, Hartmann LM, Sulkowski M, et al. Determination of trimethylbismuth in the human body after ingestion of colloidal bismuth subcitrate. Drug Metab Dispos 2009; 37: 352-358
  13. Nenov VD, Marinov P, Sabeva J, Nenov DS. Current applications of plasmapheresis in clinical toxicology. Nephrol Dial Transplant 2003; 18 (Suppl 5): v56-v58
  14. Disel NR, Açikalin A, Sebe A, Gokel Y. Utilization of plasmapheresis in the management of bismuth intoxication with acute renal failure. Saudi J Kidney Dis Transpl 2017; 28: 629-632
  15. Mirrakhimov AE, Barbaryan A, Gray A, Ayach T. The role of renal replacement therapy in the management of pharmacologic poisonings. I